Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase.
about
Effect of marine-derived n-3 polyunsaturated fatty acids on C-reactive protein, interleukin 6 and tumor necrosis factor α: a meta-analysisPPAR-gamma: Therapeutic Potential for Multiple SclerosisPGJ2 inhibition of LPS-induced inflammatory mediator expression from rat alveolar macrophagesSignaling from toxic metals to NF-kappaB and beyond: not just a matter of reactive oxygen speciesBinding of manumycin A inhibits IkappaB kinase beta activityProtection against cytokine toxicity through endoplasmic reticulum and mitochondrial stress prevention by prostacyclin synthase overexpression in insulin-producing cellsPC4/Tis7/IFRD1 stimulates skeletal muscle regeneration and is involved in myoblast differentiation as a regulator of MyoD and NF-kappaBPPARs and the cardiovascular systemOxidative stress and covalent modification of protein with bioactive aldehydesMixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanesTherapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancerThe organization and consequences of eicosanoid signalingTroglitazone, a PPAR-gamma activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-alphaContrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prThe Therapeutic Potential of Rosemary (Rosmarinus officinalis) Diterpenes for Alzheimer's DiseaseEndogenous Generation and Signaling Actions of Omega-3 Fatty Acid Electrophilic DerivativesAdvances in Our Understanding of Oxylipins Derived from Dietary PUFAsDeveloping irreversible inhibitors of the protein kinase cysteinomeX-ray crystallographic analysis of adipocyte fatty acid binding protein (aP2) modified with 4-hydroxy-2-nonenalNonsteroidal anti-inflammatory drugs suppress T-cell activation by inhibiting p38 MAPK inductionLoss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaBCytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascadeThiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational levelOmega-3 Fatty Acids and PPARgamma in CancerRole of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cellsInhibitor of nuclear factor-kappaB induction by cAMP antagonizes interleukin-1-induced human macrophage-colony-stimulating-factor expressionPeroxisome proliferator-activated receptor-gamma haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritisWhen NRF2 talks, who's listening?Redox-dependent anti-inflammatory signaling actions of unsaturated fatty acidsDynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase betaBasic principles and emerging concepts in the redox control of transcription factorsThe principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory statesNitrosylcobalamin potentiates the anti-neoplastic effects of chemotherapeutic agents via suppression of survival signalingCombined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemiaProteomic identification of protein targets for 15-deoxy-Δ(12,14)-prostaglandin J2 in neuronal plasma membraneThe fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activitiesThe eicosapentaenoic acid metabolite 15-deoxy-δ(12,14)-prostaglandin J3 increases adiponectin secretion by adipocytes partly via a PPARγ-dependent mechanismImmunopathogenesis of HIV infection in cocaine users: role of arachidonic acidCardioprotective effects of peroxisome proliferator activated receptor gamma activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor kappaB blockadeThe PPARdelta agonist GW501516 suppresses interleukin-6-mediated hepatocyte acute phase reaction via STAT3 inhibition
P2860
Q21132327-4EC72D2B-33BF-479E-9473-3CEAA44B3FC3Q21342822-ECFF5682-EDF9-45C8-BB57-EDFD131325F8Q23911525-99CF56FF-613B-492C-A2A7-41ECE758F599Q23923272-6B5EFEDB-E65E-4ECC-8DEC-FEADF2B10FDEQ24297512-68C98D4B-0086-4B42-B367-7812364C93AFQ24299562-CAB680FE-07F3-4B2A-A28F-6DE8F6837665Q24626949-B10D8646-BDC8-4568-B0AC-56A7F44AFC23Q24642728-AC252DAE-361C-4DFF-89AD-40E6D3B82649Q24649676-3966C188-9D71-47C8-95DC-BE7A1ED7E759Q24671911-CD7DB9FF-E406-4BCB-B3A6-E965AD6359CDQ24681630-A786353B-04FC-4380-AC89-B39006825A64Q24683703-9B5FE223-D032-45D2-8439-4B2D7EF5E3BDQ24793384-7B1797A1-95BF-410B-BADF-592BABB8753BQ24812924-F950967A-39B1-4681-AA5A-A858726DA2A0Q26768487-30ADFB73-022E-4A1F-AF37-130AB3B47257Q26784513-0493F436-53AC-46FA-867C-69E2C3A07139Q27014988-59FC0A5F-ADB5-447E-A26B-66421529890FQ27027983-E02A421B-5679-4B18-95B4-5FB34DADB686Q27662024-395D5507-64FD-4C6C-AD84-4AC6227D7240Q28191438-5D79EBDD-AAE2-4A3C-A543-3E55CF8283EBQ28201706-82D2027D-A6B4-466F-A00E-1B3DBC0EFF3BQ28211233-35FA40A0-46A4-44AB-B056-FB8C60710B20Q28253220-A8E7EF68-17F4-4CF4-9EA2-17441459F787Q28292907-96D9FDEC-C15E-4FFE-85C7-3F9DB0B5B4D2Q28345289-9FC238B4-AB59-4A16-8378-5ED2216D63CEQ28365595-7AD51099-1F54-4E05-A3FA-D511814C91C4Q28365786-EE8B21D5-5C19-4CB2-BB45-B00D57F1D58DQ28384223-3022BC61-DC28-47AD-A906-E531BBC3DAECQ28386488-7BCB10C8-7B55-4DDA-BCB0-C62829A37363Q28390372-1386D0C9-2BFF-4D32-B7C7-35A830F1A1DAQ28391506-D289D33E-495E-42CB-874E-F01B94466A8CQ28396048-22033FF9-D48E-4CC8-A54E-FF675E8467C5Q28471740-41295679-3511-4A38-8C09-C54C332B1D26Q28472176-CC9824B3-CB71-4196-A08D-69FA7D4D01E2Q28477446-96095C57-78EA-458B-8621-A9AA3857A1C0Q28513582-88A386B8-0E64-42E1-A99D-4CBC4B0C87E6Q28533399-862EA4AE-9165-40FA-8B7F-B1CCC5A67421Q28542673-B11A7FDA-4D70-408E-8F7A-2B92196ED0DAQ28570331-EBD04879-B52F-456C-8074-08B5FDC81451Q28572346-588AC9AA-C6A3-4828-86BF-C9BDC8ECEA79
P2860
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase.
@ast
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase.
@en
type
label
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase.
@ast
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase.
@en
prefLabel
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase.
@ast
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase.
@en
P2093
P356
P1433
P1476
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase.
@en
P2093
P2888
P304
P356
10.1038/47520
P407
P577
2000-01-01T00:00:00Z
P6179
1018375485